Literature DB >> 17210733

Asynchronous administration of xenon and hypothermia significantly reduces brain infarction in the neonatal rat.

J L Martin1, D Ma, M Hossain, J Xu, R D Sanders, N P Franks, M Maze.   

Abstract

BACKGROUND: Neonatal asphyxia causes long-term neurological and behavioural impairment in the developing brain. Concurrent administration of xenon and hypothermia synergistically reduces long-term damage in a rat model of neonatal asphyxia. This study sought to investigate whether asynchronous administration of xenon and hypothermia is capable of combining synergistically to provide neuroprotection.
METHODS: Seven-day-old rats were subjected to right common carotid artery occlusion followed by 90 min hypoxia with 8% oxygen. After a 1 h recovery period, rats received asynchronous administration of mild hypothermia (35 degrees C) and xenon (20%) with a 1 or 5 h gap between interventions, xenon (20%) alone, or mild hypothermia (35 degrees C) alone. Infarct volume in the brain was measured 4 days after injury.
RESULTS: Administration of hypothermia or xenon alone, 1 and 6 h after the hypoxic ischaemic insult, respectively, provided no neuroprotection. Asynchronous administration of xenon and hypothermia at a 1 h interval produced a significant reduction in infarct volume [93 (7) vs 74 (8); P < 0.05]. Reduction in infarct volume was also present when hypothermia and xenon were asynchronously administered with an intervening gap of 5 h [97 (5) vs 83 (3); P < 0.05].
CONCLUSIONS: This finding provides a rationale for investigating the combined use of hypothermia and xenon in a progressive manner for the management of neonatal asphyxia. Thus, hypothermia can be administrated at the site of delivery and xenon can be administered later.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17210733     DOI: 10.1093/bja/ael340

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  19 in total

Review 1.  [Current developments in xenon research. Importance for anesthesia and intensive care medicine].

Authors:  A Brücken; M Coburn; S Rex; R Rossaint; M Fries
Journal:  Anaesthesist       Date:  2010-10       Impact factor: 1.041

Review 2.  Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?

Authors:  Nicola J Robertson; Sidhartha Tan; Floris Groenendaal; Frank van Bel; Sandra E Juul; Laura Bennet; Matthew Derrick; Stephen A Back; Raul Chavez Valdez; Frances Northington; Alistair Jan Gunn; Carina Mallard
Journal:  J Pediatr       Date:  2012-02-09       Impact factor: 4.406

Review 3.  Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection.

Authors:  Robert Dickinson; Nicholas P Franks
Journal:  Crit Care       Date:  2010-08-12       Impact factor: 9.097

Review 4.  Neuroprotective Properties of Xenon.

Authors:  Mervyn Maze; Timo Laitio
Journal:  Mol Neurobiol       Date:  2019-11-22       Impact factor: 5.590

5.  Xenon improves neurologic outcome and reduces secondary injury following trauma in an in vivo model of traumatic brain injury.

Authors:  Rita Campos-Pires; Scott P Armstrong; Anne Sebastiani; Clara Luh; Marco Gruss; Konstantin Radyushkin; Tobias Hirnet; Christian Werner; Kristin Engelhard; Nicholas P Franks; Serge C Thal; Robert Dickinson
Journal:  Crit Care Med       Date:  2015-01       Impact factor: 7.598

6.  Combination of therapeutic hypothermia and other neuroprotective strategies after an ischemic cerebral insult.

Authors:  Joline Goossens; Saïd Hachimi-Idrissi
Journal:  Curr Neuropharmacol       Date:  2014-09       Impact factor: 7.363

7.  Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury.

Authors:  Philip D Loetscher; Jan Rossaint; Rolf Rossaint; Joachim Weis; Michael Fries; Astrid Fahlenkamp; Yu-Mi Ryang; Oliver Grottke; Mark Coburn
Journal:  Crit Care       Date:  2009-12-17       Impact factor: 9.097

8.  XENON in medical area: emphasis on neuroprotection in hypoxia and anesthesia.

Authors:  Ecem Esencan; Simge Yuksel; Yusuf Berk Tosun; Alexander Robinot; Ihsan Solaroglu; John H Zhang
Journal:  Med Gas Res       Date:  2013-02-01

9.  Neuroprotective therapies after perinatal hypoxic-ischemic brain injury.

Authors:  Felipe Goñi de Cerio; Idoia Lara-Celador; Antonia Alvarez; Enrique Hilario
Journal:  Brain Sci       Date:  2013-03-05

10.  Combined treatment of xenon and hypothermia in newborn rats--additive or synergistic effect?

Authors:  Hemmen Sabir; Lars Walløe; John Dingley; Elisa Smit; Xun Liu; Marianne Thoresen
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.